Evaluation of Antithrombotic STrategies in STEMI Patients in China
NCT ID: NCT03510832
Last Updated: 2018-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
8000 participants
OBSERVATIONAL
2018-03-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism in China
NCT03185377
Thrombolytic and Interventional Treatment of Pulmonary Embolism
NCT03886194
Pulmonary Embolism: Mechanism and Therapeutic Innovation
NCT05360992
Changes of Cardiopulmonary Function After Thrombolysis in Patients With Pulmonary Embolism
NCT04757129
The China Pulmonary Thromboembolism Registry Study
NCT02943343
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
STEMI patients undergoing Emergent PCI
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. STEMI patients undergoing emergent PCI
3. Signed informed consent
Exclusion Criteria
2. Other severe diseases (e.g., liver failure, renal failure and advanced stage of cancer)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shandong Provincial Hospital
OTHER_GOV
Qianfoshan Hospital
OTHER
Jinan Central Hospital
OTHER
The Second Hospital of Shandong University
OTHER
Shandong Province Third hospital
OTHER
The 5th People's Hospital of Jinan
UNKNOWN
The 6th People's Hospital of Jinan
UNKNOWN
The Affiliated Hospital of Qingdao University
OTHER
Qingdao Municipal Hospital
OTHER
Qingdao Central Hospital
OTHER
Qingdao Haici Hospital
OTHER
Chengyang People's Hospital
UNKNOWN
Qingdao Westcoast New Area Central Hospital
UNKNOWN
Qingdao Jiaozhou Central Hospital
UNKNOWN
Pingdu People's Hospital
UNKNOWN
Central Hospital of Zibo
OTHER
Zibo First Hospital
OTHER
Linzi District People's Hospital
UNKNOWN
Peking University Care Luzhong Hospital
OTHER
Tengzhou Central People's Hospital
OTHER_GOV
Dongying People's Hospital
OTHER
Shengli Oilfield Hospital
OTHER
Yantaishan Hospital
UNKNOWN
Yantai Yuhuangding Hospital
OTHER
Yantai Affiliated Hospital of Binzhou Medical University
OTHER
Longkou People's Hospital
UNKNOWN
Laizhou City People's Hospital
OTHER
Weifang People's Hospital
OTHER
Weifang Medical University
OTHER
Weifang Traditional Chinese Hospital
UNKNOWN
Yidu Central Hospital of Weifang
UNKNOWN
Qingzhou People's Hospital
UNKNOWN
Shouguang people's Hospital
UNKNOWN
Jining Medical University
OTHER
Jining First People's Hospital
OTHER
Wenshang People's Hospital
UNKNOWN
Yanzhou Branch of Affiliated Hospital of Jining Medical University
UNKNOWN
Jinxiang People's Hospital
UNKNOWN
Taian City Central Hospital
OTHER
Taishan Medical University Affiliated Hospital
OTHER
Feicheng People's Hospital
UNKNOWN
Weihai Municipal Hospital
OTHER
Weihai Central Hospital
OTHER
Binzhou Medical University
OTHER
Zhouping People's Hospital
UNKNOWN
Dezhou People's Hospital
OTHER
Ningjin County People's Hospital
UNKNOWN
Liaocheng People's Hospital
OTHER
The Second People's Hospital of Liaocheng
UNKNOWN
Linyi People's Hospital
OTHER
Feixian People's Hospital
UNKNOWN
Heze Municipal Hospital
OTHER
Yuncheng County People's Hospital
UNKNOWN
Heze Luxin Cardiovascular and Cerebrovascular Hospital
UNKNOWN
Jining Integrative Medicine Hospital
UNKNOWN
Tianjin Chest Hospital
OTHER
Henan Provincial People's Hospital
OTHER
Inner Mongolia People's Hospital
OTHER
Anhui Provincial Hospital
OTHER_GOV
Qilu Hospital of Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuguo Chen, Dr
Role: PRINCIPAL_INVESTIGATOR
Qilu Hospital of Shandong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qilu Hospital of Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QLEmer201802
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.